Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · IEX Real-Time Price · USD
7.24
-0.08 (-1.09%)
At close: Jul 19, 2024, 4:00 PM
7.31
+0.07 (0.97%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Amneal Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for AMRX stock have an average target of 8.00, with a low estimate of 7.00 and a high estimate of 9.00. The average target predicts an increase of 10.50% from the current stock price of 7.24.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 6, 2024.
Analyst Ratings
The average analyst rating for AMRX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $6.25 → $8 | Strong Buy | Maintains | $6.25 → $8 | +10.50% | May 6, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $7 → $9 | Strong Buy | Reiterates | $7 → $9 | +24.31% | May 6, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $6 → $8 | Buy | Maintains | $6 → $8 | +10.50% | Mar 21, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $5.5 → $6.25 | Strong Buy | Maintains | $5.5 → $6.25 | -13.67% | Mar 4, 2024 |
| Barclays | Barclays | Buy Maintains $6 → $8 | Buy | Maintains | $6 → $8 | +10.50% | Jan 29, 2024 |
Financial Forecast
Revenue This Year
2.72B
from 2.39B
Increased by 13.47%
Revenue Next Year
2.61B
from 2.72B
Decreased by -3.87%
EPS This Year
0.63
from -0.48
EPS Next Year
0.59
from 0.63
Decreased by -6.42%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 2.8B | 3.0B | 3.1B |
| Avg | 2.6B | 2.7B | 2.9B |
| Low | 2.5B | 2.5B | 2.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 16.0% | 13.1% | 14.7% |
| Avg | 9.1% | 3.7% | 6.0% |
| Low | 2.5% | -4.8% | -6.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.66 | 0.72 | 0.92 |
| Avg | 0.59 | 0.66 | 0.75 |
| Low | 0.53 | 0.58 | 0.65 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 22.5% | 40.4% |
| Avg | - | 11.2% | 14.7% |
| Low | - | -2.3% | -1.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.